Feb. 22, 2022 — Ivermectin, the controversial anti-parasitic drug, does not help treat mild to moderate COVID-19, another new study has found. “The study findings do not support the use of ivermectin for patients with COVID-19,” researchers said in the study published last week in JAMA Internal Medicine. The trial took place at 20 public … Read more
Dec. 22, 2021 – The FDA on Wednesday granted emergency use authorization of a new antiviral pills to treat people with symptomatic COVID-19. Pfizer’s ritonavir, name brand Paxlovid, can now be taken by patients age 12 and up who weigh at least 88 pounds. The antiviral is only for people who test positive for coronavirus, … Read more
Oct. 15, 2021 — Machine learning has come a long way in the quarter-century since a computer nicknamed Deep Blue shocked the world by beating chess champion Garry Kasparov. Today, when our smartphones have far more computing power than Deep Blue, scientists have trained their sights on even bigger opponents, including potentially fatal illnesses like … Read more
Infectious Diseases Society of America: “Monoclonal Antibodies.” The New England Journal of Medicine: “Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.” William Fales, MD, medical director, Michigan Department of Health and Human Services, Division of EMS and Trauma. Lindsay Petty, MD, infectious disease doctor, University of Michigan. Eli Lilly: “Emergency Use Authorization (EUA) for the … Read more
Sept. 2, 2020 — There’s no evidence to support the use of convalescent plasma to treat COVID-19 patients, and doctors should not consider it a standard of care until more research is completed, a U.S. National Institutes of Health expert panel said Tuesday. “There are insufficient data to recommend either for or against the use … Read more